drugset / Trial / NCT00532558
Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to determine the reduction of LDL-cholesterol level after treatment with 50 mg per day of lapaquistat acetate once daily (QD).
Timeline
- Start
- 2007-10
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapaquistat acetate | Small molecule | 50 mg | Oral |